Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q1 EPS of ($0.81), $0.08 worse than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.